|
Originally published In Press as doi:10.1074/jbc.M206542200 on November 12, 2002
J. Biol. Chem., Vol. 278, Issue 5, 3357-3362, January 31, 2003
Transcription Dependence of Chromosomal Gene Targeting
by Triplex-forming Oligonucleotides*
Margaret A.
Macris and
Peter M.
Glazer
From the Departments of Therapeutic Radiology and Genetics, Yale
University School of Medicine, New Haven, Connecticut 06520-8040
Triplex-forming oligonucleotides (TFOs) recognize
and bind to specific DNA sequences and have been used to modify gene
function in cells. To study factors that might influence triplex
formation at chromosomal sites in mammalian cells, we developed a
restriction protection assay to detect triplex-directed psoralen
crosslinks in genomic DNA prepared from TFO-transfected cells. Using
this assay, we detected binding of a G-rich TFO to a chromosomal site even in the absence of transcription when high concentrations of the
TFO were used for transfection. However, experimental induction of
transcription at the target site, via an ecdysone-responsive promoter,
resulted in substantial increases (3-fold or more) in target site
crosslinking, especially at low TFO concentrations. When RNA polymerase
activity was inhibited, even in the ecdysone-induced cells, the level
of TFO binding was significantly decreased, indicating that
transcription through the target region, and not just transcription factor binding, is necessary for the enhanced chromosomal targeting by
TFOs. These findings provide evidence that physiologic activity at a
chromosomal target site can influence its accessibility to TFOs and
suggest that gene targeting by small molecules may be most effective at
highly expressed chromosomal loci.
*
This work was supported by grants from the Leukemia and
Lymphoma Society (to P. M. G.) and National Institutes of Health
Grant CA64186.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 203-737-2788;
Fax: 203-737-2630, E-mail: peter.glazer@yale.edu.
Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Duca, P. Vekhoff, K. Oussedik, L. Halby, and P. B. Arimondo
The triple helix: 50 years later, the outcome
Nucleic Acids Res.,
September 1, 2008;
36(16):
5123 - 5138.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-H. Kim, P. E. Nielsen, and P. M. Glazer
Site-directed gene mutation at mixed sequence targets by psoralen-conjugated pseudo-complementary peptide nucleic acids
Nucleic Acids Res.,
December 3, 2007;
35(22):
7604 - 7613.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Brunet, M. Corgnali, F. Cannata, L. Perrouault, and C. Giovannangeli
Targeting chromosomal sites with locked nucleic acid-modified triplex-forming oligonucleotides: study of efficiency dependence on DNA nuclear environment
Nucleic Acids Res.,
September 11, 2006;
34(16):
4546 - 4553.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. G. Uil, H. J. Haisma, and M. G. Rots
Therapeutic modulation of endogenous gene function by agents with designed DNA-sequence specificities
Nucleic Acids Res.,
November 1, 2003;
31(21):
6064 - 6078.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|